Supplemental material for Pfizer Oncology’s Breast Cancer Pipeline – SABCS 2024

Congress materials may include information for investigational products or for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Regulatory approval of investigational products or uses is dependent on the completion of the study programs and review by regulatory authorities. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information. The clinical trial information is available at www.clinicaltrials.gov. This information is current as of November 1, 2024.

Publication Details

Journal
Pfizer
Published
2024-12-11
DOI
https://doi.org/10.25454/pfizer.figshare.27368061
Primary Topic
N-Heterocyclic Carbenes in Organic and Inorganic Chemistry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Supplemental material for Pfizer Oncology’s Breast Cancer Pipeline – SABCS 2024

Pfizer
N-Heterocyclic Carbenes in Organic and Inorganic Chemistry
article

Supplemental material for Pfizer Oncology’s Breast Cancer Pipeline – SABCS 2024

article en

Abstract

Congress materials may include information for investigational products or for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Regulatory approval of investigational products or uses is dependent on the completion of the study programs and review by regulatory authorities. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information. The clinical trial information is available at www.clinicaltrials.gov. This information is current as of November 1, 2024.

Pfizer
Good health and well-being
Openalex Percentile: Top 59%
N-Heterocyclic Carbenes in Organic and Inorganic Chemistry
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Supplemental material for Pfizer Oncology’s Breast Cancer Pipeline – SABCS 2024 · Pfizer (2024) | TGRS Research Map | TGRS